819 related articles for article (PubMed ID: 11240957)
1. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
[TBL] [Abstract][Full Text] [Related]
2. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Furukawa H; Takahashi M; Nakamura K; Kaneko F
J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
[TBL] [Abstract][Full Text] [Related]
3. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
4. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
[TBL] [Abstract][Full Text] [Related]
5. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
Shimada Y; Takehara K; Sato S
J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
[TBL] [Abstract][Full Text] [Related]
7. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
Song TW; Sohn MH; Kim ES; Kim KW; Kim KE
Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
[TBL] [Abstract][Full Text] [Related]
8. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2002 Feb; 127(2):270-3. PubMed ID: 11876749
[TBL] [Abstract][Full Text] [Related]
9. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.
Furukawa H; Nakamura K; Zheng X; Tojo M; Oyama N; Akiba H; Nishibu A; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
J Dermatol Sci; 2004 Jun; 35(1):35-42. PubMed ID: 15194145
[TBL] [Abstract][Full Text] [Related]
10. CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis.
Nakatani T; Kaburagi Y; Shimada Y; Inaoki M; Takehara K; Mukaida N; Sato S
J Allergy Clin Immunol; 2001 Feb; 107(2):353-8. PubMed ID: 11174204
[TBL] [Abstract][Full Text] [Related]
11. Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis.
Morita E; Hiragun T; Mihara S; Kaneko S; Matsuo H; Zhang Y; Dekio S
J Dermatol Sci; 2004 May; 34(3):237-40. PubMed ID: 15113595
[TBL] [Abstract][Full Text] [Related]
12. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
[TBL] [Abstract][Full Text] [Related]
13. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
[TBL] [Abstract][Full Text] [Related]
14. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
15. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
Vestergaard C; Johansen C; Christensen U; Just H; Hohwy T; Deleuran M
Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis.
Hashimoto S; Nakamura K; Oyama N; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
J Dermatol Sci; 2006 Nov; 44(2):93-9. PubMed ID: 17008059
[TBL] [Abstract][Full Text] [Related]
17. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice.
Vestergaard C; Deleuran M; Gesser B; Larsen CG
Exp Dermatol; 2004 Apr; 13(4):265-71. PubMed ID: 15086343
[TBL] [Abstract][Full Text] [Related]
18. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases.
Saeki H; Tamaki K
J Dermatol Sci; 2006 Aug; 43(2):75-84. PubMed ID: 16859899
[TBL] [Abstract][Full Text] [Related]
19. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
[TBL] [Abstract][Full Text] [Related]
20. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
